Clinical Trial Results:
Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic Preservative-Free Formulation of Latanoprost 50μg/ml Eye Drops vs Xalatan® Eye Drops in Patients with Open Angle Glaucoma, or Ocular Hypertension.
Summary
|
|
EudraCT number |
2017-002910-29 |
Trial protocol |
GR |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
09 Mar 2019
|
First version publication date |
09 Mar 2019
|
Other versions |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.